Europe — EMA
Avastin (Bevacizumab)
Avastin (bevacizumab) is a cancer treatment medication used to slow tumor growth by targeting blood vessel formation. This intravenous therapy is often combined
Request sourcing
What is Bevacizumab?
Avastin (bevacizumab) is a cancer treatment medication used to slow tumor growth by targeting blood vessel formation. This intravenous therapy is often combined with other treatments.
What is Bevacizumab used for?
Avastin is primarily used in cancer therapy to inhibit the growth of new blood vessels that supply tumors. It is often administered alongside chemotherapy for conditions like colorectal, lung, kidney, and cervical cancers. The medication works by targeting vascular endothelial growth factor (VEGF), which is essential for tumor blood supply.
What are the side effects of Bevacizumab?
Common effects of Avastin may include high blood pressure, fatigue, and changes in appetite. Some patients may experience more severe side effects such as bleeding or wound healing complications. Always consult a healthcare provider for personalized advice.
What precautions apply to Bevacizumab?
Avastin should be handled with care, as it is administered intravenously by healthcare professionals. Patients should inform their doctor about any existing medical conditions or allergies. Regular monitoring is essential during treatment to manage potential side effects.
What does Bevacizumab interact with?
Avastin may interact with other medications, particularly those that affect blood clotting or wound healing. It is important to discuss all current medications with a healthcare provider to avoid adverse interactions. Alcohol and certain supplements may also impact treatment efficacy.



